With Hong Kong, We Go Further
Key Milestones and Development Plan
2025 and Beyond
- Move into the wet-laboratory enabled building in the Hong Kong-Shenzhen Innovation and Technology Park (HSITP) with an expansion of floor area to around 20,000 square feet.
- Jointly establish the "GBA Clinical Trial Collaboration Platform" with the GBA International Clinical Trial Centre in the Shenzhen Park.
- Establish the "Real-World Study and Application Centre" to support new drug development.
- Establish the "Hong Kong Clinical Trial Digital Portal."
- Establish the "Clinical Trial Academy."
2024
- Established at the Central Government-Aided Emergency Hospital, the temporary office and the biobank officially opens.
2023
- The Chief Executive proposed the establishment of the Greater Bay Area International Clinical Trial Institute (GBAICTI) in the Policy Address.
Outlook and Vision
The Government will continue to enhance Hong Kong's clinical trial capability on all fronts and facilitate the translation of innovative biomedical research results into clinical applications.
Extend the R&D network and expedite clinical trials.
Accelerate approval for registration of new drugs in Hong Kong, the Mainland and overseas.
Attract top-notch innovative enterprises to set up operations in Hong Kong.
Mission
Enhance Hong Kong's clinical trial capacity and efficiency, to develop Hong Kong into an international health and medical innovation hub.
Strategic Location
Hong Kong
One Country and Two Systems, Strong Support of the Motherland, Closely Connected to the World.
Hetao area
One Zone, Two Parks, Technological Innovation, Institutional Innovation, Cross-boundary Facilitation.
Guangdong-Hong Kong-Macao Greater Bay Area (GBA)
Population Over 86 Million, Special Measures of Using HK Registered Drugs and Medical Devices Used in HK Public Hospitals in GBA.
Governance
Wholly owned by the Government
All members of the Board are appointed by the Secretary for Health.
Operated by the LKS Faculty of Medicine of The University of Hong Kong.
Functions
GBAICTI
A one-stop clinical trial support platform
Coordinate clinical trial resources in the public and private healthcare sectors.
Establish collaboration network and training programmes in GBA.
Continuously review and improve different clinical trial processes.
Advise on long-term planning for clinical trial infrastructure and resources.
Key Facilities
Temporary Office and Biobank Facility
Equipped with several executive offices, meeting rooms, and a multipurpose space.
Biobank Facility managed by the Hospital Authority in collaboration with The Chinese University of Hong Kong.
Sample collection, deposition and access comply with internationally recognised ethical standards.
Properly store data in independent laboratory information management system.
Total area approx.
7,000
sq.ft
Storage for more than
400,000
such as tissues, blood, cells and DNA.
Storage Equipment
Two liquid nitrogen (gas phase) storage tanks
Eleven ultra-low temperature freezers
Our Management
Prof. Bernard M. Y. Cheung
GBAICTI Chief Executive Officer
MA, MB BChir (Cantab), PhD (Cantab), FRCP (Edin). FRCP (Lond), FHKCP, FHKAM (Medicine), FBHS, FBPhS
Contact Us
info@gbaicti.hk